Interestingly, GuoQiang Qu et al. observed that rhotekin (RTKN), a Rho effector protein, could upregulate the expression of MCM2 to increase cell proliferation, migration, and invasion in colon cancer (Qu et al. 2015). The gene discussed is MCM2; the disease is malignant colon neoplasm.